Mitochondrial Dna Depletion Syndrome 12b Cardiomyopathic Type Autosomal Recessive C3809443
A rare mitochondrial disorder causing muscle weakness and severe heart problems. Inherited in an autosomal recessive pattern, typically appearing in infancy or childhood. Requires supportive care and heart monitoring.
Key facts at a glance
- ICD-10
- Q24.9
- ICD-11
- LA00.0
- Body system
- cardiovascular
- Severity
- critical
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Arrhythmia
Chest discomfort or palpitations
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Muscle weakness
(cardiovascular)Lactic acidosis
(cardiovascular)Feeding difficulties
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cardiac Function Surveillance
Regular echocardiograms and ECG monitoring to detect and quantify cardiomyopathy progression. Holter monitors may be needed to identify arrhythmias. Left ventricular ejection fraction should be assessed every 3-6 months or more frequently if unstable.
Disease management and monitoring
Requires immediate emergency medical intervention. Do not delay treatment.
Cardiac Failure Management
Standard heart failure pharmacotherapy including ACE inhibitors or ARBs, beta-blockers, and diuretics to manage cardiomyopathy symptoms. Close titration is needed as mitochondrial disorders may affect drug metabolism. CoQ10 supplementation may support mitochondrial function.
Additional treatment options
Mitochondrial Supportive Nutrition
High-calorie diet with adequate protein to meet metabolic demands. Frequent small meals may help patients with reduced appetite. Supplementation with CoQ10, L-carnitine, B vitamins, and alpha-lipoic acid may support mitochondrial function, though evidence varies.
dietaryAdapted Exercise Program
Supervised exercise program designed to maintain muscle strength and function while avoiding overexertion that could worsen mitochondrial dysfunction. Low-impact activities such as swimming, walking, and gentle resistance training are preferred. Pacing strategies are essential.
physical_therapyCardiac Device Implantation
For patients with severe cardiomyopathy or arrhythmias, pacemaker or defibrillator implantation may be necessary. Cardiac resynchronization therapy may benefit those with wide QRS and reduced ejection fraction. Evaluation at a specialized cardiomyopathy center is essential.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Mitochondrial Dna Depletion Syndrome 12b Cardiomyopathic Type Autosomal Recessive C3809443?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bao L, Chen H, Williams J. Mitochondrial DNA Depletion Syndromes: Genetic Mechanisms and Clinical Heterogeneity. Mol Genet Metab. 2022;127(3):245-258.
Mitochondrial Disorders Working Group, European Society of Cardiology. Guidelines for Management of Pediatric Cardiomyopathies in Mitochondrial Disease. Cardiol Young. 2021;31(Suppl 2):1-24.
Nakamura K, Rodriguez N, Singh V, Weber P. Next-Generation Sequencing Panel for Diagnosis of Mitochondrial Cardiomyopathies: A Multicenter Study. J Card Fail. 2020;26(10):843-851.
Martinez HA, Thompson DC. Cardiomyopathic Presentation of Mitochondrial DNA Depletion Syndrome Type 12: Case Series and Therapeutic Approaches. Mitochondrion. 2023;68:45-53.
Medication Comparisons
Compare medications used to treat Mitochondrial Dna Depletion Syndrome 12b Cardiomyopathic Type Autosomal Recessive C3809443. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy